Marta Smeda
Overview
Explore the profile of Marta Smeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smeda M, Maleki E, Jasztal A
Cancer Metastasis Rev
. 2024 Nov;
44(1):2.
PMID: 39576347
While the prevalence of cancer-associated thrombosis (CAT) is high in cancer patients, its molecular mechanisms have not been fully elucidated. Moreover, the risks of recurrent CAT events and mortality remain...
2.
Zoladz J, Grandys M, Smeda M, Kij A, Kurpinska A, Kwiatkowski G, et al.
J Physiol
. 2024 Feb;
602(5):855-873.
PMID: 38376957
Myoglobin (Mb) plays an important role at rest and during exercise as a reservoir of oxygen and has been suggested to regulate NO bioavailability under hypoxic/acidic conditions. However, its ultimate...
3.
Smeda M, Jasztal A, Maleki E, Bar A, Sternak M, Kwiatkowski G, et al.
Front Mol Biosci
. 2022 Dec;
9:1050112.
PMID: 36504711
Ageing is a major risk factor for cancer metastasis but the underlying mechanisms remain unclear. Here, we characterised ageing effects on cancer-induced endothelial-mesenchymal transition (EndMT) in the pulmonary circulation of...
4.
Smeda M, Hosseinzadeh Maleki E, Pelesz A, Chlopicki S
Pharmacol Rep
. 2022 Dec;
74(6):1182-1197.
PMID: 36463349
Immuno-thrombosis of COVID-19 results in the activation of platelets and coagulopathy. Antiplatelet therapy has been widely used in COVID-19 patients to prevent thrombotic events. However, recent analysis of clinical trials...
5.
Smeda M, Stojak M, Przyborowski K, Sternak M, Suraj-Prazmowska J, Kus K, et al.
Front Pharmacol
. 2022 Mar;
13:834472.
PMID: 35295330
Activation of the coagulation cascade favours metastatic spread, but antithrombotic therapy might also have detrimental effects on cancer progression. In this study, we characterized the effects of dabigatran, a direct...
6.
Augustyniak K, Chrabaszcz K, Smeda M, Stojak M, Marzec K, Malek K
Appl Spectrosc
. 2021 Jun;
76(4):439-450.
PMID: 34076540
Label-free molecular imaging is a promising utility to study tissues in terms of the identification of their compartments as well as chemical features and alterations induced by disease. The aim...
7.
Chrabaszcz K, Kaminska K, Song C, Morikawa J, Kujdowicz M, Michalczyk E, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33418894
The current understanding of mechanisms underlying the formation of metastatic tumors has required multi-parametric methods. The tissue micro-environment in secondary organs is not easily evaluated due to complex interpretation with...
8.
Olkowicz M, Tomczyk M, Debski J, Tyrankiewicz U, Przyborowski K, Borkowski T, et al.
Metabolism
. 2020 Oct;
114:154400.
PMID: 33058853
Objective: Dyslipidaemia is a major risk factor for myocardial infarction that is known to correlate with atherosclerosis in the coronary arteries. We sought to clarify whether metabolic alterations induced by...
9.
Smeda M, Chlopicki S
Cardiovasc Res
. 2020 Jul;
116(10):e118-e121.
PMID: 32707576
No abstract available.
10.
Chrabaszcz K, Meyer T, Bae H, Schmitt M, Jasztal A, Smeda M, et al.
Analyst
. 2020 Jun;
145(14):4982-4990.
PMID: 32515437
Lungs, due to their high oxygen availability and vascularization, are an ideal environment for cancer cell migration, metastasis and tumour formation. These processes are directly connected with extracellular matrix (ECM)...